Recently Viewed

You have no recently viewed item.

Recently Viewed

You have no recently viewed item.

Dyronib 50mg Tablet

Current price is: ₹1,650.00. Original price was: ₹12,187.50.

You saved ₹10,537.50 (86%)

Brand Name: Dyronib
Category: Anti Cancer
Manufacturer: Hetero Healthcare Limited
Composition: Dasatinib
Minimum Order Quantity: 2

60 Tablet(s) In a Bottle

Dasatinib is the active ingredient in Dyronib 50mg Tablet and is used to treat chronic myeloid leukaemia in patients who cannot tolerate other medicines due to side effects.

Tell your healthcare team about all drugs you take. Do not use it during pregnancy or while breastfeeding. Do not drive if you feel lightheaded or if you have vision problems.

Product Description

Dasatinib is the active ingredient in Dyronib 50mg Tablet and is used to treat chronic myeloid leukaemia in patients who cannot tolerate other medicines due to side effects.


Uses of Dyronib 50mg Tablet:

  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia

How does the Dyronib 50mg Tablet work?

Tyrosine kinase inhibitors (TKIs) such as dasatinib are targeted against BCR-ABL, the abnormal protein produced by the Philadelphia chromosome. Dasatinib blocks this protein, and thus blocks the signals that tell cancer cells to grow and multiply. This kills the cancer cells.


How to Use & Dosage

Oral with or without food. The recommended starting dose for CML is 100 mg once a day. The standard recommended dose for ALL is 140 mg once a day. Dose adjustments may be necessary based on clinical response and tolerability.

Take this medicine by mouth with a full glass of water as directed. It may be taken with or without food. Do not take grapefruit juice. Do not crush or chew this medicine. Take it as directed, on a regular basis. Do not take antacids containing aluminum, calcium or magnesium for 2 hours before or after using this medication. Ask your doctor about using this medication in children.


Possible Side Effects:

  • Diarrhea
  • Nausea
  • Fatigue
  • Headache
  • Rash
  • Myelosuppression (e.g., low blood cell counts)
  • Pleural effusion
  • Cardiac issues (e.g., arrhythmias)

Safety Advise:

🫁 Lungs

It’s not known if Dyronib is safe for people with breathing problems. Please talk to your healthcare provider.

🤰 Pregnancy

The use of Dyronib 50mg tablets during pregnancy is not recommended due to the established risks to the developing foetus. Please talk to your doctor.

🤱 Breastfeeding

Do not use the Dyronib 50mg tablet during pregnancy. There is evidence that the fetus may be poisoned by medication. Talk to your health care provider.

🍷 Alcohol

It is unknown whether it is safe to drink alcohol while taking a Dyronib 50mg tablet. Be sure to speak with your health care professional.

🚗 Driving

You may not be able to drive because of the side effects of the Dyronib 50mg Tablet. Do not drive if you experience dizziness, blurred vision or any other symptoms that could affect your ability to drive. Please consult your medical professional.


Storage Instructions:

Store at ambient temperature. The recommended range is 20° to 25°C. Store in a dry place, away from moisture. Keep in original packaging, out of direct sunlight. Keep out of reach of children.


References

  1. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. New Delhi: Jaypee Brothers Medical Publishers.
  2. Katzung BG, Vanderah TW. Basic and Clinical Pharmacology. 15th ed. New York: McGraw Hill.
  3. Lombardo LJ, Lee FY, Chen P, et al. Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. Journal of Medicinal Chemistry. 2004;47(27):6658-6661.
  4. Montani D, Bergot E, Günther S, et al. Pulmonary arterial hypertension in patients treated by dasatinib. Circulation. 2012;125(17):2128-2137.
  5. Bristol-Myers Squibb Company. Sprycel (dasatinib) Tablets Prescribing Information. Full Prescribing Information, U.S. Food and Drug Administration.

Disclaimer:

IHS Enterprises’s primary objective is to guarantee the accuracy, reliability, and specialist review of the information it provides to customers. The contents and information provided on this website are for informational purposes only. They should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician for guidance and any questions you may have about any condition or medication. If you do read anything from IHS Enterprises, please do not discount or delay in seeking competent medical advice. We want to enhance the doctor-patient relationship, not substitute it.


Manufacturer Details:

Marketer details

Name: Hetero Healthcare Limited

Address: S.no: 80-84, Melange towers, PatrikaNagar, Madhapur, Hyderabad, Telangana-500081.

Country of origin: India